TALZENNA CAPSULE 0.35MG

Regulatory Information

HSA regulatory responsibility and product classification details

RegistrantPFIZER PRIVATE LIMITED

Drug Type

Therapeutic

Forensic Class

Prescription Only

HSA Singapore Classification

Dosage Form

CAPSULE

Route of Administration

ORAL

ATC Code

L01XK04

Pharmaceutical Manufacturer

PFIZER PRIVATE LIMITED

Manufacturers

Excella GmbH & Co. KG

Ingredient Name

Talazoparib tosylate eqv Talazoparib

Strength

0.35 mg

Drug MonographTalazoparib

Talzenna Capsule PI.pdf

Approved: May 21, 2025